Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of COVID-19 by Nebulization of Inteferon Beta 1b Efficiency and Safety Study

NCT04469491 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire, Amiens as lead sponsor.

NCT NCT04469491
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04469491 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of COVID-19 by Nebulization of Inteferon Beta 1b Efficiency and Safety Study
Lead sponsor
Centre Hospitalier Universitaire, Amiens
Phase
Phase 2
Overall status
Active, not recruiting
Start date
September 20, 2020
Completion date
December 31, 2025
Enrollment
74 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, interferon, nebulization